Zobrazeno 1 - 7
of 7
pro vyhledávání: '"V. Nagarjuna Maturu"'
Autor:
R.O. Allehebi, V. Nagarjuna Maturu, B. Mahboub, S. Bavbek, P. Fernandez, D.J. Cano Rosales, C. Soares, G. Abreu, R. Valladares, J. Queiroz, P. Menezes, A. Raimondi, F. Aziz, E. Pizzichini, M. Laucho-Contreras, S. Noibi
Publikováno v:
A31. GLOBAL AND ENVIRONMENTAL INFLUENCES IN ASTHMA.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c21beea7088bb208cfcfa374a294dc21
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1313
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1313
Autor:
Khushboo, Saxena, V Nagarjuna, Maturu
Publikováno v:
Cureus.
Background Intrapleural fibrinolytic therapy (IPFT) with streptokinase (STK), urokinase (UK), and alteplase remains a common practice for managing loculated pleural effusions (LPEs). However, very limited data are available on the comparative efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53f484ff382e3ff8099d4c4d5d66e553
https://doi.org/10.7759/cureus.26271
https://doi.org/10.7759/cureus.26271
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e17805 (2011)
Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore preventing the development of atherosclerosis. The polymorphisms of PON1 gene are known to affect the PON1
Externí odkaz:
https://doaj.org/article/1665cdfc16674c8ea53c7a5c13f747c1
Autor:
Gagandip Singh, Surjit Singh, V. Nagarjuna Maturu, Yash Paul Sharma, Nidhi Gupta, Kiran Dip Gill
Publikováno v:
Indian Journal of Clinical Biochemistry. 28:248-254
Human serum paraoxonase-1 (PON1), an enzyme on HDL prevents oxidation of LDL thereby preventing the development of atherosclerosis. Studies done so far have lead to conflicting results. As studies are lacking in North-West Indian Punjabi’s, a disti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7360c8a0f307fb83e445a4e7b99a0492
https://doi.org/10.1007/s12291-012-0260-5
https://doi.org/10.1007/s12291-012-0260-5
Autor:
Digamber Behera, V. Nagarjuna Maturu
Publikováno v:
Tropical Hemato-Oncology ISBN: 9783319182568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27d840e873547c355f6706b725791c63
https://doi.org/10.1007/978-3-319-18257-5_37
https://doi.org/10.1007/978-3-319-18257-5_37
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 5, p e17805 (2011)
PLoS ONE, Vol 6, Iss 5, p e17805 (2011)
Background Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore preventing the development of atherosclerosis. The polymorphisms of PON1 gene are known to affec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57edbaf56926988d548ec4726088335
http://europepmc.org/articles/PMC3101202
http://europepmc.org/articles/PMC3101202
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.